需术后放疗女性是否应考虑即刻自体乳房再造?前瞻性结局分析
该前瞻性队列纳入175例接受乳房切除术后放疗并行腹部游离皮瓣自体乳房再造的患者,其中即刻再造108例、延迟再造67例。1年总体并发症率两组相似(即刻25.9%对延迟26.9%,p=0.54)。术后1年和2年BREAST-Q各评估领域满意度两组相当,提示即刻自体乳房再造在特定患者和中心可安全考虑。
要点
- 术后放疗背景下即刻与延迟自体乳房再造1年并发症率相似(25.9%对26.9%,p=0.54)。
- 延迟再造者术前BREAST-Q乳房满意度及心理社会、性健康评分显著更低(p<0.0001)。
- 术后1年和2年两组BREAST-Q评估领域满意度相当,皮瓣受照未损害患者报告结局。
核心结论
- 在乳房切除术后放疗背景下,即刻自体乳房再造似乎是可考虑的安全选择,适用于特定患者和中心。
- 从患者角度评估的乳房美学与生活质量未因皮瓣暴露于放疗而受损。
研究设计与样本
- 前瞻性队列研究,数据来自Mastectomy Reconstruction Outcomes Consortium研究。
- 共175例接受术后放疗并行即刻或延迟腹部游离皮瓣自体乳房再造的患者纳入分析。
- 即刻再造108例,延迟再造67例;93.5%的即刻再造在单一中心完成。
主要发现
- 1年总体并发症率即刻组25.9%、延迟组26.9%,两组相似(p=0.54)。
- 延迟再造组术前乳房满意度及心理社会、性健康评分显著低于即刻再造组(p<0.0001)。
- 术后1年和2年,两组在评估的BREAST-Q领域满意度相当。
关键数值与推荐
- 并发症评估时间点为再造术后1年和2年。
- 患者报告结局采用BREAST-Q问卷,于术前及术后1年、2年评估。
- 统计方法包括双变量分析和混合效应回归模型。
临床怎么用
- 对于需术后放疗的乳房切除患者,即刻自体乳房再造可作为特定条件下的安全选项加以考虑。
- 决策时应结合患者个体情况与中心经验,并告知延迟再造者术前满意度可能更低。
局限性
- 93.5%的即刻再造在单一中心完成,可能限制结果外推。
- 证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In women who require postmastectomy radiation therapy, immediate autologous breast reconstruction is often discouraged. The authors prospectively evaluated postoperative morbidity and satisfaction reported by women undergoing delayed or immediate autologous breast reconstruction in the setting of postmastectomy radiation therapy. METHODS: Patients enrolled in the Mastectomy Reconstruction Outcomes Consortium study, who received postmastectomy radiotherapy and underwent immediate or delayed free abdominally based autologous breast reconstruction, were identified. Postoperative complications at 1 and 2 years after reconstruction were assessed. Patient-reported outcomes were evaluated using the BREAST-Q questionnaire preoperatively and at 1 and 2 years postoperatively. Bivariate analyses and mixed-effects regression models were used to compare outcomes. RESULTS: A total of 175 patients met the authors' inclusion criteria. Immediate reconstructions were performed in 108 patients and delayed reconstructions in 67 patients; 93.5 percent of immediate reconstructions were performed at a single center. Overall complication rates were similar based on reconstructive timing (25.9 percent immediate and 26.9 percent delayed at 1 year; p = 0.54). Patients with delayed reconstruction reported significantly lower prereconstruction scores (p < 0.0001) for Satisfaction with Breasts and Psychosocial and Sexual Well-being than did patients with immediate reconstruction. At 1 and 2 years postoperatively, both groups reported comparable levels of satisfaction in assessed BREAST-Q domains. CONCLUSIONS: From this prospective cohort, immediate autologous breast reconstruction in the setting of postmastectomy radiation therapy appears to be a safe option that may be considered in select patients and centers. Breast aesthetics and quality of life, evaluated from the patient's perspective, were not compromised by flap exposure to radiation therapy. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Billig J, Jagsi R, Qi J, et al. Should Immediate Autologous Breast Reconstruction Be Considered in Women Who Require Postmastectomy Radiation Therapy? A Prospective Analysis of Outcomes. Plast Reconstr Surg. 2017. PMID: 28198770. doi:10.1097/PRS.0000000000003331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。